US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.91

+0.25501.37%

Post-market: 18.910.00000.00%16:04 EDT

Volume:10.43K

Turnover:195.91K

Market Cap:109.70M

PE:- -

High:18.91

Open:18.83

Low:18.67

Close:18.66

52wk High:21.88

52wk Low:14.38

Shares:5.80M

Float Shares:5.80M

Volume Ratio:0.35

T/O Rate:0.18%

Dividend:0.71

Dividend Rate:3.78%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

CSPC Pharmaceutical - Sys6090 (Jmt108) Granted Fast Track Designation by U.S. FDA for Mss/Pmmr Mcrc

THOMSON REUTERS

CSPC Pharmaceutical - Sys6010 Meets Primary Endpoint of Progression-Free Survival in Phase Iii Synstar-01 Study

THOMSON REUTERS

CSPC Pharmaceutical Group Stock Rallies 1.2% in Hong Kong, Underperforms Competitors

CICC Maintains Outperform Rating on Innovent Biologics with Target Price Set at HK$118.30

-BUZZ-China's Innovent Biologics Hits All-Time High on H1 Growth

Hong Kong Biotech Sector Surges Again as Innovative Drug Stocks Lead Gains, INNOVENT BIO Hits Record High

China, HK Stocks Track Global Tech Rebound; Gold Miners Rally

Hong Kong's SSY Group H1 Profit Rises on Infusion Solutions Growth

Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength

Morning Market Wrap: Hong Kong Shares Rise 0.68% as Copper Stocks Take the Lead

Mainland Benchmarks Edge Higher in Morning Trade; Nonferrous Metals and Brokerages Lead While Optical Modules Retreat; Hang Seng and Tech Index Climb Over 1% on Biotech Surge

China's Akeso Jumps on Progress of Immunotherapy Drug for Cancer Treatment

AKESO Surges Over 9% in Session as Evonex Achieves Positive Phase III Results in Biliary Tract Cancer

Akeso's Ivonescimab Meets Primary Endpoint in Phase 3 Biliary Tract Cancer Trial

MT Newswires Live

Akeso Says Ivonescimab Plus Chemo Meets Primary Endpoint

INNOVENT BIO Surges 6% on Robust H1 Earnings, Sets Ambitious 2030 Revenue Target

HK Stock Market Highlights: Haizhi Tech's H1 FY2026 Revenue Jumps 70.4% as Agent Business Takes Off

JPMorgan Raises Stake in Innovent Bio With HK$241M Share Purchase

AKESO's Novel Dual Antibody Achieves Positive Phase III Results in Biliary Tract Cancer, Marking First Solid Tumor Expansion Beyond Lung Cancer

Akeso - Ivonescimab Plus Chemo Meets Primary Endpoint with Significant Os Benefit in 1L BTC

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/KURE/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.91,"timestamp":1788465600000,"preClose":18.655,"halted":0,"volume":10426,"hourTrading":{"tag":"盘后","latestPrice":18.91,"preClose":18.91,"latestTime":"16:04 EDT","volume":6,"amount":113.46000000000001,"timestamp":1788465847026,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.013669257571696541,"floatShares":5800979,"shares":5800979,"eps":0,"marketStatus":"Post-Mkt","change":0.255,"latestTime":"09-03 16:06:13 EDT","open":18.83,"high":18.91,"low":18.6655,"amount":195914,"amplitude":0.013106,"askPrice":20.61,"askSize":100,"bidPrice":17.09,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788480000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":18.655,"sharesOutstanding":4750002,"nav":18.46,"aum":108936686.05,"dividendRate":0.0378,"bidAskSpread":0.00342,"postHourTrading":{"tag":"盘后","latestPrice":18.91,"preClose":18.91,"latestTime":"16:04 EDT","volume":6,"amount":113.46000000000001,"timestamp":1788465847026,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.34927,"impliedVol":0.2767,"impliedVolPercentile":0.5754},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5800979,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.34927,"shares":5800979,"dividePrice":0.7148,"high":18.91,"amplitude":0.013106,"preClose":18.655,"low":18.6655,"week52Low":14.3797,"pbRate":"--","week52High":21.875,"institutionHeld":0,"latestPrice":18.91,"eps":0,"divideRate":0.0378,"volume":10426,"delay":0,"ttmEps":0,"open":18.83,"prevYearClose":17.04,"prevWeekClose":18.925,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":19.215,"twentyDayClose":17.47,"sixtyDayClose":14.5156},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662797532","title":"CSPC Pharmaceutical - Sys6090 (Jmt108) Granted Fast Track Designation by U.S. FDA for Mss/Pmmr Mcrc","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797532","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797532?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:10","pubTimestamp":1787739002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0I5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1807302812.USD","LU1993786604.SGD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","IE0008368742.USD","LU0315179316.USD","LU1960683339.HKD","LU0314109678.HKD","LU1008478684.HKD","KURE","LU1226288170.HKD","LU0140636845.USD","LU1813983027.USD","BK1191","LU1152091754.HKD","LU2039709279.SGD","LU0072913022.USD","01093","LU1226287792.SGD","LU1951186391.HKD","SG9999004220.SGD","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1515","IE00BZ08YT58.USD","LU0326950275.SGD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU0067412154.USD","LU1152091168.USD","LU1226287529.USD","LU1226287875.USD","LU1328277881.USD","IE0008369823.USD","LU0880133367.SGD","LU0501845795.SGD","LU1226288253.USD","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662792719","title":"CSPC Pharmaceutical - Sys6010 Meets Primary Endpoint of Progression-Free Survival in Phase Iii Synstar-01 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2662792719","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662792719?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:01","pubTimestamp":1787738500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0KM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1960683339.HKD","LU1226287875.USD","KURE","LU0067412154.USD","LU1328277881.USD","LU1152091168.USD","LU1226287529.USD","LU0314109678.HKD","IE00B031HY20.USD","LU0880133367.SGD","LU1951186391.HKD","BK1521","LU0072913022.USD","IE00BZ08YR35.GBP","LU0501845795.SGD","LU1008478684.HKD","LU0326950275.SGD","LU1226288170.HKD","LU1152091754.HKD","IE00BZ08YT58.USD","IE00B5MMRT66.SGD","LU1807302812.USD","LU0315179316.USD","LU0140636845.USD","LU2039709279.SGD","BK1515","LU1226287792.SGD","IE00B543WZ88.USD","BK1191","01093","LU1993786604.SGD","LU1813983027.USD","LU1226288253.USD","SG9999004220.SGD","IE00BZ08YS42.EUR","IE0008368742.USD","IE0008369823.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662796413","title":"CSPC Pharmaceutical Group Stock Rallies 1.2% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662796413","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662796413?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:33","pubTimestamp":1787733180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. advanced 1.2% to 9.53 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 25652.97.This was the stock's third consecutive day of gains.CSPC Pharmaceutical Group Ltd. closed 18% short of its 52-week high of HK$11.63, which the company achieved Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. rose 2.1%, SSY Group Ltd. rose 5.2%, and United Laboratories International Holdings Ltd. fell 0.8%.Trading volume totaled 190.3 million shares, compared to the 50-day average of 100.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","KURE","LU1226287529.USD","LU0326950275.SGD","LU0880133367.SGD","LU0315179316.USD","LU0501845795.SGD","LU1226287875.USD","IE0008368742.USD","LU2039709279.SGD","LU1226288170.HKD","LU1807302812.USD","LU0314109678.HKD","LU1008478684.HKD","BK1191","BK1515","01093","IE00B543WZ88.USD","IE00BZ08YT58.USD","BK1521","LU1328277881.USD","SG9999004220.SGD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","LU0067412154.USD","LU1152091754.HKD","LU0072913022.USD","LU1226288253.USD","LU1226287792.SGD","LU1152091168.USD","LU1960683339.HKD","LU1993786604.SGD","IE00B031HY20.USD","LU1951186391.HKD","LU0140636845.USD","IE0008369823.USD","LU1813983027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139243882","title":"CICC Maintains Outperform Rating on Innovent Biologics with Target Price Set at HK$118.30","url":"https://stock-news.laohu8.com/highlight/detail?id=1139243882","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139243882?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:11","pubTimestamp":1787724693,"startTime":"0","endTime":"0","summary":"CICC has released a research report stating that it maintains an outperform rating on INNOVENT BIO (01801), keeping its 2026 net profit attributable to shareholders forecast at RMB 2.43 billion....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","LU0502904849.HKD","HK0000165453.HKD","LU2097828474.EUR","LU2328871848.SGD","EWH","01801","LU2097828631.EUR","LU1188198961.HKD","LU2242644610.SGD","LU0244354667.USD","KURE","LU2097828557.USD","LU0455707207.USD","LU2097828714.EUR","LU0326950275.SGD","BK1589","LU0463099449.HKD","LU2488822045.USD","LU2097828805.USD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662540760","title":"-BUZZ-China's Innovent Biologics Hits All-Time High on H1 Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662540760","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662540760?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:09","pubTimestamp":1787724588,"startTime":"0","endTime":"0","summary":"-BUZZ-China's Innovent Biologics hits all-time high on H1 growthAdds top pct gainer in key index in third bullet, earnings details in fourth bullet** Shares of China's Innovent Biologics1801.HKjump 12","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N03U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","HK0000165453.HKD","LU2097828474.EUR","BK1161","LU2328871848.SGD","01801","LU1188198961.HKD","LU2242644610.SGD","LU0502904849.HKD","LU0455707207.USD","LU2488822045.USD","LU2097828631.EUR","LU0463099449.HKD","LU2097828557.USD","BK1583","LU0244354667.USD","KURE","BK1589","LU0326950275.SGD","LU2097828714.EUR","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149059268","title":"Hong Kong Biotech Sector Surges Again as Innovative Drug Stocks Lead Gains, INNOVENT BIO Hits Record High","url":"https://stock-news.laohu8.com/highlight/detail?id=1149059268","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149059268?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:02","pubTimestamp":1787724134,"startTime":"0","endTime":"0","summary":"Hong Kong healthcare stocks continued their upward momentum on August 26, with innovative drug developers taking over the leadership baton from the CXO sector. Cansino Biologics Inc. soared more than...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU2097828474.EUR","LU1188198961.HKD","LU2097828714.EUR","LNGR","LU2097828557.USD","06978","688185","LU2488822045.USD","MEDX","BK1589","BK1161","BK1583","KURE","159992","HK0000165453.HKD","LU2242644610.SGD","BK1574","LU0244354667.USD","159646","LU0463099449.HKD","LU2097828631.EUR","01801","LU0502904849.HKD","FLHK","LU1969619763.USD","LU2328871848.SGD","LU0455707207.USD","LU2097828805.USD","IBBQ","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662640467","title":"China, HK Stocks Track Global Tech Rebound; Gold Miners Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2662640467","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662640467?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:27","pubTimestamp":1787718464,"startTime":"0","endTime":"0","summary":"China, HK stocks track global tech rebound; gold miners rallySHANGHAI, August 26 (Reuters)-China and Hong Kong stocks advanced on Wednesday, tracking a broader rebound in global markets as sentiment i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USXF","LU2028103732.USD","LU2242649171.HKD","LU1880398554.USD","LU1048596156.SGD","IE00BJTD4V19.USD","2NVD.UK","LU0348805143.USD","LU0594300179.USD","LU0051755006.USD","LU0943347566.SGD","LU0949170772.SGD","IE00B1XK9C88.USD","ABFL","LU0244354667.USD","LU2191332357.HKD","SG9999002828.SGD","IE00B3M56506.USD","LU1400636574.HKD","LU1935043536.SGD","IE00BDCRKT87.USD","LU0738911758.USD","IE00B0169N27.USD","LU1044875133.USD","LU2257852520.SGD","LU0348735423.USD","LU0868494617.USD","LU1956131251.USD","LU1868837300.USD","SMH","LU1115378108.SGD","LU0267386448.USD","LU0323240290.USD","LU1935042488.USD","LU0211328371.USD","SG9999015358.SGD","IE0003895053.USD","LU0293314216.USD","LU2476274720.SGD","LU0106252389.USD","LU1642822792.SGD","LU1366192091.USD","IE00BDRTCR15.USD","LU1868836591.USD","LU2087625088.SGD","SGXZ86797644.SGD","LU0315178854.USD","NVD","NVDS.UK","LU1201861165.SGD","LU1066051498.USD","LU2213496289.HKD","LU2347655073.USD","SG9999018857.SGD","LU1623119135.USD","IE00B3SWFQ91.USD","IE000KEQY171.SGD","LU1568876251.USD","LU0862451837.USD","LU2065170008.USD","LU2242650005.HKD","LU1935042215.USD","SG9999002232.USD","LU0256863811.USD","LU0215105999.USD","LU1720051108.HKD","LU0320764755.SGD","LU0531971595.HKD","LU0890818403.SGD","LU1770034418.SGD","LU1815336760.USD","LU0211977185.USD","LU1934455277.USD","LU2065171311.SGD","LU3102509885.SGD","LU0449515922.USD","LU1328277881.USD","LU2272731865.HKD","LU0444973449.USD","LU0593848301.USD","LU0608807433.USD","BK1142","LU2089283258.USD","LU2458330169.SGD","LU0455707207.USD","LU1116320737.USD","LU0444971666.USD","LU2087589342.USD","LITU","LU1035773651.USD","LU1496350502.SGD","ESLG","LU0784639295.USD","LU2168563687.JPY","LU2226246903.HKD","LU2491049909.HKD","SG9999001424.SGD","LU0117844026.USD","LU2357305700.SGD","LU2491050071.SGD","LU0205194284.USD","LU0395794307.EUR","HK0000532082.HKD","IE0034224299.USD","03115","IE00B19Z4B17.USD","LU1145028129.USD","LU0648000940.SGD","LU1935042991.SGD","DIPS","LU1961090484.USD","LU2097828557.USD","SNVDAmain","METV","LU0287142896.SGD","BK1502","LU0689626769.HKD","FDTX","LU0254981946.USD","LU1064131342.USD","LU2462157665.USD","LU2237443622.USD","LU2746668974.SGD","ALBmain","LU0441854154.USD","LU2637965513.SGD","LU0607220059.USD","SMHX","COHR","LU0345770993.USD","LU1674673428.USD","LU0545039389.USD","IE00B4YYXB79.USD","LU0234570918.USD","LU0345768740.USD","LU1655091459.SGD","LU1880383440.USD","LU0052750758.USD","LU1504937902.USD","LU0882574139.USD","BK4532","NVII","LU0823041008.USD","LU1267930730.SGD","LU0203202063.USD","NVDY","SG9999015945.SGD","LU1323998911.USD","LU0158827781.USD","LU0348783662.USD","IE0009G5SDU7.USD","IE0008368304.USD","LU0109392836.USD","LU0228367735.SGD","LU1267930573.SGD","NVD3.UK","IE00BZ1G4Q59.USD","LU0719512351.SGD","IE00B5MMRT66.SGD","LU0466842654.USD","LU0823421416.USD","LU2505996681.GBP","LU0477156797.USD","LU1282651121.HKD","NVC","LU0205193047.USD","IE00BKDWB100.SGD","LU0354030511.USD","LU1794554557.SGD","LU2125154778.USD","BK4534","LU2750360997.AUD","LU0011963245.USD","SG9999002562.SGD","LU0173614495.USD","BK4567","LU2430703251.USD","SGXZ31699556.SGD","LU1951198990.SGD","TEK","SG9999014575.USD","LU0511384066.AUD","LU0708995401.HKD","IE00BFSS7M15.SGD","LU1066053197.SGD","IE00BMPRXQ63.HKD","LU0109391861.USD","LU0861579265.USD","LU2322448791.USD","LU0985320562.USD","LU0588545904.SGD","LU0261950983.USD","LU1691799644.USD","LU0762542818.HKD","LU0786609619.USD","LU1791710400.SGD","LU2125909759.SGD","LU0348827113.USD","LU0724617625.USD","IE00BZ08YT58.USD","LU2045819591.USD","LU0348723411.USD","LU0499858438.USD","LU1969619763.USD","LU0128522744.USD","ILDR","LU0329678337.USD","LU0196878994.USD","LU0819121731.USD","LU2097828805.USD","IE00B0JY6N72.USD","LU0264606111.USD","IE00BMPRXR70.SGD","LU1400636491.USD","LU0133085943.USD","BK1608","LITE","LU0197773160.USD","LU0370786039.SGD","NVYY","IE000W1ABFV2.USD","IE0032431581.USD","LU0128525929.USD","IE00BN29S564.USD","TRFK","LU0096362180.USD","SG9999015986.USD","LU0476273544.USD","LU0572944931.SGD","LU1992135472.HKD","LU1051768304.USD","LU2168564149.EUR","LU0862451753.SGD","LU0012050646.USD","LU0965508806.USD","IE00BK4W5M84.HKD","LU1303224171.USD","IE00BPRC5H50.USD","LU1880398471.USD","LU2394011477.USD","LU1551013342.USD","LU2471134796.USD","SG9999000418.SGD","IE00BK4W5L77.USD","LU1868836914.USD","LU0543330566.HKD","LU0320765059.SGD","LU2087621335.USD","LU2100268510.USD","LU0229945570.USD","LU0348825331.USD","LU0823397103.USD","LU1960683339.HKD","LU2092627202.USD","IE0004091025.USD","LU1974910355.USD","LU0323239441.USD","LU0049853897.USD","LU2488822045.USD","LU1699723380.USD","IE00B19Z8W00.USD","LU0488056044.USD","LU0132412106.USD","LU0964807845.USD","LU2237443465.HKD","LU2279689827.SGD","LU0791591158.USD","TYLG","IE0031619046.USD","LU0056508442.USD","VT","BK4020","CMAG","LITG","HK0000304805.HKD","IE00B19Z8X17.USD","LU2264538146.SGD","LU2125909247.SGD","LU1688375341.USD","LU0823421333.USD","SG9999014542.SGD","LU0130518102.USD","LU1934455863.HKD","LU1282649810.SGD","LU0164872284.USD","LU1934455194.USD","LU1044874839.SGD","LU2413666426.HKD","LU2023250330.USD","LU1548497426.USD","IE0034235188.USD","BK4585","LU0820562030.AUD","LU0157215616.USD","IE0003U64NQ7.SGD","SG9999014559.SGD","LU2360106780.USD","COHC","LU1366333091.USD","LU2023250504.SGD","IE00B66KJ199.SGD","83115","BK4554","LU0061474705.USD","LU0359201612.USD","LU1035775433.USD","BK4548","LU2077746001.SGD","LU2361044949.HKD","LU2463028550.USD","LU0762540952.USD","FAI","IE00BYXW3230.USD","LU0084288322.USD","LU1044876610.USD","THMR","LU2360032135.SGD","LU1282651048.USD","LU1366334651.USD","BABA","LU0541501648.USD","LU0348814723.USD","LU1719994722.HKD","LU2778985437.USD","HK0000151867.HKD","LU1571399168.USD","LU1323610961.USD","LU2487616109.SGD","SG9999001689.USD","LU1839511570.USD","BK1575","LU1023057109.AUD","LU1951200564.SGD","LU0106261612.USD","IE00BKPKM429.USD","LU0868486357.SGD","LU0611395673.USD","LU0820561818.USD","LU2896262040.SGD","BK1588","LU0345769631.USD","LU0856984785.SGD","LU2286300806.USD","HSTECH","LU0106959298.USD","LU0898667661.SGD","LU1037948897.HKD","HK0000819398.USD","LU0210528500.USD","LU1642822529.SGD","LU2097828631.EUR","BK1161","LU0240877869.USD","LU0572940350.SGD","LU0238689110.USD","LU1791710582.SGD","LU0348784397.USD","LU2361045086.USD","LITC","LU0795875169.SGD","IE00BFSS8Q28.SGD","LU0170899867.USD","LU0528227936.USD","CNEQ","LU0820561909.HKD","SGXZ80539844.SGD","SG9999001093.SGD","SG9999018865.SGD","LU0174119429.USD","IE00BJJMRX11.SGD","LU2417539215.USD","LU0048584097.USD","LU2999663052.SGD","SGXZ90724238.SGD","LU0819123356.HKD","LU0211327993.USD","BK4157","BK4614","LU0889565833.HKD","LU2092937148.SGD","HK0000286598.CNH","LU0708995583.HKD","LU2399975544.HKD","LU2456880835.USD","LU2860962120.EUR","LU2168564065.EUR","LU0345776255.USD","LU0054450605.USD","LU2097829019.USD","SGXZ81514606.USD","LU0130103400.USD","LU0589944569.HKD","07200","LU1551013425.SGD","BKF","LU0154236417.USD","LU2552382215.SGD","LU2602419157.SGD","LU1037948541.HKD","NVDB","LU0164880469.USD","LU2954938101.SGD","HK0000306701.USD","NVDA","LU0240878834.USD","LU2491050154.USD","LU0417516738.SGD","LU0942090050.USD","SG9999000459.SGD","SG9999004220.SGD","HK0000306685.HKD","LU2449936058.SGD","513600","COHX","LU1282649141.HKD","LU0577902611.USD","LU2236285917.USD","LU0203201768.USD","LU0106259558.USD","LU3063872942.SGD","BK1589","LU0328353924.USD","LU0823040885.USD","IE00BHPRN162.USD","LU2237443978.SGD","BK4503","LU2471134952.CNY","LU1732800096.USD","BK4608","LU0831093199.SGD","LU0345768153.USD","LU1804176565.USD","LU1280957306.USD","LU1989764748.USD","LU1568876335.HKD","LU2461242641.AUD","LU0143863198.USD","IE00BQXX3F31.USD","01801","BK4587","LU0070217475.USD","LU0463099449.HKD","LU1242518857.USD","CXSE","BK4588","LU0047713382.USD","LU0726765562.USD","LU1810669033.SGD","LU1188198961.HKD","LU2097828474.EUR","LU2433249047.HKD","NVDX","LU1852331112.SGD","LU0011850046.USD","LU2272731600.USD","LU0502904849.HKD","LU1981816686.USD","LU0456846285.SGD","IE0034235295.USD","LU2111349929.HKD","SOXY","LU2326559502.SGD","LU0683600562.USD","07388","LU0823039010.USD","LU2097344431.USD","ESUM","LU0029875118.USD","LU0128522157.USD","LU1935043023.USD","LU0107464264.USD","LU1989772923.USD","LU1979441026.SGD","LFGY","LU1066051225.USD","LU2361044865.SGD","LU2242644610.SGD","WISE","LU0181495838.USD","LITZ","SG9999004303.SGD","LU2065171402.SGD","LU0054237671.USD","LU1868837136.USD","LU2097344357.USD","IE00BQXX3D17.EUR","09115","LU0143551892.USD","LU2430703178.SGD","SGXZ62798434.SGD","LU2458330243.SGD","LU0069063385.USD","LU0048388663.USD","LU0320764599.SGD","SOXQ","LU2249611893.SGD","IE00B543WZ88.USD","IE00BJLML261.HKD","BK1586","LU0642271901.SGD","LU2168564222.USD","LU0737861699.HKD","TTEQ","LU0053666078.USD","ANV","LU0259732245.USD","LU0163747925.USD","LU0965509283.SGD","LU0957791311.USD","LU0965509101.SGD","LU0094547139.USD","ROM","LU0345775950.USD","LU0417516571.SGD","LU0651947912.USD","LU1629891620.HKD","KWEB","IE00B7SZL793.SGD","LU0823413587.USD","LU0918141705.HKD","LU1211504680.USD","LU0608807946.USD","AGOX","LU2328871848.SGD","LU1923623000.USD","LU0061475181.USD","LU0210527791.USD","LU0061474960.USD","LU0577902538.SGD","LU0979878070.USD","LU1481107354.HKD","LU2125909593.SGD","LU0210526637.USD","BK1249","BK4543","LU1048588211.SGD","IXN","LU2360107168.USD","LU1439103000.SGD","LU2089985449.USD","BK1584","LU2237443382.USD","LU0029874905.USD","LU0353189763.USD","CHAT","BK1501","LU0323591593.USD","IE0001KFT4U8.USD","SG9999014898.SGD","LU0630378429.USD","LU0197773673.USD","LU1917777945.USD","LU0315179316.USD","LU0316494557.USD","HK0000165453.HKD","LU0353189680.USD","NVIW.SI","LU0043850808.USD","IE00B775H168.HKD","LU0871576103.HKD","IE00BKVL7J92.USD","LU1515016050.SGD","LU1732799900.SGD","LU0588545490.SGD","LU0158827948.USD","LU0261947096.USD","BK4612","LU0187121727.USD","LU2054465674.USD","LU0831103253.SGD","SPRX","LU2420271590.USD","IE0004445239.USD","LU1674673691.USD","LU0164865239.USD","NVDL","LU0256863902.USD","SGXZ99366536.SGD","LU1202635105.USD","LU2552382132.HKD","HSI","SG9999002463.SGD","LU0149534421.HKD","LU0225283273.USD","LU0561508036.HKD","ARTY","LU0516423091.SGD","BK1517","LU2152927971.USD","LU0828237940.HKD","LU1718418525.SGD","XLK","LU0342679015.USD","LU0494093205.USD","LU1633808545.USD","LU2083900584.USD","LU1989764664.SGD","LU1983260115.SGD","LU2471134523.USD","LU2746668461.USD","LU0541502299.USD","BK4549","LU0143863784.USD","LU0310800379.SGD","LU1400636657.SGD","LU0588545730.USD","LU1880383366.USD","NVD2.UK","SHOC","LU0235996351.USD","IE00BJTD4N35.SGD","3NVD.UK","BK4605","LU0650527681.SGD","LU1116320901.HKD","SG9999017495.SGD","LU0675040207.SGD","LU2750360641.GBP","LU1316542783.SGD","SG9999014567.USD","IE00BJJMRY28.SGD","LU0228659784.USD","NVDD","LU2543165471.USD","LU0266013472.USD","LU0175139822.USD","LU2347655156.SGD","LU0276348264.USD","LU0198837287.USD","CHPX","LU0347712357.USD","LU1244550577.SGD","LU2931357623.SGD","09988","LU2063271972.USD","LU2168564495.EUR","LU2244417387.USD","LU0396098781.USD","LU0165289439.USD","LU1778281490.HKD","LU1244550221.USD","LU0553294199.USD","LU0700851271.USD","LU0326950275.SGD","LU2381873111.SGD","LU2125910500.SGD","LU2237957811.SGD","LU0384037296.USD","LU2265009873.SGD","AIPI","LU2237438978.USD","LU2506951792.HKD","LU0791590937.USD","SG9999014906.USD","LU0648948544.HKD","BK1521","IE00B3S45H60.SGD","BK4527","LU2476274308.USD","IE00BQXX3C00.GBP","LU0138981039.USD","LU0797268264.HKD","LU2430703095.HKD","SG9999015952.SGD","LU1923622614.USD","07788","LU0348783233.USD","LU1282649067.USD","LU2047632596.USD","BK4551","HK0000304797.USD","LU0823038988.USD","BK4592","LITX","SGXZ23171101.USD","HBBD.SI","IE000Q6AESB8.SGD","TTXU","LU1105468828.SGD","LU0588546209.SGD","LU1224709979.USD","07500","BK1610","IE00BZ08YR35.GBP","NULC","LU0531970944.HKD","LU0039217434.USD","BK1615","LU0096374516.USD","LU0320764243.SGD","LU0265550946.USD","HK0000320264.USD","LU0169518387.USD","LU0265550359.USD","LU0359202008.SGD","LU1003077747.HKD","LU0516423174.USD","LU0865486749.SGD","LU2756315664.SGD","LU0072462343.USD","IE00BZ08YS42.EUR","LU0307460666.USD","82800","LU0348788117.USD","LU1803068979.SGD","BK4533","LU0577902371.SGD","LAZR","02800","FOTO","LU1831875114.USD","SG9999014914.USD","LU0048597586.USD","MHImain","LU0082616367.USD","IE0009356076.USD","LU1989772840.SGD","LU0006306889.USD","LU2592432038.USD","LU1914381329.SGD","SG9999001903.USD","LU0577902454.USD","IE000ITXATA3.USD","FTEC","LU2290526834.HKD","LU2089284900.SGD","LU1242518931.SGD","LU0557290698.USD","LU0327786744.USD","LU1769817096.USD","GB00BDT5M118.USD","LU1813983027.USD","LU2452424414.USD","LU0431992006.USD","LU1051769294.HKD","LU0828237510.HKD","LU0348816934.USD","LU0149721374.USD","HHImain","IE00BZ199S13.USD","LU0823397285.USD","LU2473716301.USD","BK4581","LU2065169927.USD","LU0886674414.USD","LU2271345857.HKD","COHQ","NVDO","VGT","LU0210533765.USD","LU0912757837.SGD","IE00B7KXQ091.USD","LU1861215975.USD","LU0516422440.USD","SNVD.UK","LU1769817179.HKD","LU1224444064.USD","USD","EFIV","LU0472753341.HKD","IE00BMPRXN33.USD","LU1282648689.USD","LU0737861772.HKD","LU0821914370.USD","LU0456827905.SGD","02833","LU0640476718.USD","LU1328615791.USD","LU0251132253.USD","LU1721428933.USD","NVDS","LU0210536198.USD","HK0000914686.HKD","HK0000320223.HKD","LU1712237335.SGD","LU0354030438.USD","LU2462591277.SGD","LU2106854487.HKD","LU0345770308.USD","NVDQ","BK1591","03037","BK4579","LU0823426480.USD","LDEM","LU0251144936.SGD","LU0594300419.USD","LU1127390331.HKD","LU1807302812.USD","LU1993786604.SGD","LU2097828714.EUR","LU2250418816.HKD","LU0516422952.EUR","LU1868837565.USD","LU2237957902.USD","SG9999006514.SGD","IE00B1BXHZ80.USD","SG9999001226.SGD","LU0127658192.USD","IE00B775SV38.USD","IE00B19Z9505.USD","LU0289739343.SGD","LU0499858602.USD","SG9999002224.SGD","LU0117841782.USD","LU2125909916.SGD","07300","LU1429558221.USD","LU0543330483.HKD","LU0231483743.USD","LU1861127337.USD","LU1496350171.SGD","LU2294711713.HKD","IE00B4JS1V06.HKD","LU1119994496.HKD","LU2211815571.USD","LU1048484197.HKD","BK4529","LU1821325948.USD","LU0080751232.USD","LU0274383776.USD","89988","SG9999015978.USD","LU1069347547.HKD","LU2505996509.AUD","LUMA","LU0823434583.USD","BK1618","LU0061477393.USD","LU1992135399.USD","LU1670756490.USD","LU2552382058.USD","LU2293587155.HKD","SG9999006597.SGD","LU0097036916.USD","LU0823414551.USD","HK0000914660.USD","LU0096364046.USD","LU1261432733.SGD","BK4550","SG9999014880.SGD","LU2237443895.HKD","LU2471134879.HKD","LU0072462426.USD","IE0034235303.USD","LU0572939691.SGD","COHH","LU0289960550.SGD","JGRO","LU0417516902.SGD","LU1988902786.USD","LU0029864427.USD","LU0640798160.USD","LU2294711473.HKD","SNPE","LU0918141887.USD","LU1814569148.SGD","LU0345769128.USD","LU2108987350.USD","LU1366334578.USD","LU0449509016.USD","LU1244550494.USD","LU2039709279.SGD","SOXX","LU0823413660.USD","IE00B5949003.HKD","LU0873338254.USD","BK4598","LU0823426308.USD","LU1196710864.SGD","03419","LU0788109477.HKD","LU0957808578.USD","LU0708994859.HKD","SG9999000327.SGD","LU0672654166.SGD","IE00B5TLWC47.USD","HK0000107257.USD","LU1267930490.SGD","EGGY","LU0634319403.HKD","BK1583","LU0140636845.USD","LU1066051811.HKD","LU1861220033.SGD","LU0516422366.SGD","SG9999014674.SGD","LU1084165304.USD","IE00BWXC8680.SGD","LU2023251221.USD","LU1232071149.USD","CLSE","LU0661504455.SGD","IETC","KURE","LU0417517546.SGD","LU0048580855.USD","LU0308772762.SGD","IE0004445015.USD","LU1435385759.SGD","LU0651946864.USD","LU0672654240.SGD","LU0823414478.USD","LU1645745479.HKD","LU1144417596.USD","LU0329678170.USD","LU0605514214.HKD","NVDU","NVDW","LU2133065610.SGD","SPTE","IE0005OL40V9.USD","LU2247934214.USD","LU0057025933.USD","LU2125154935.USD","LU0795875086.SGD","IE00BD6J9T35.USD","LU0310799852.SGD","LU0081259029.USD","LU1069344957.HKD","LU2756315318.SGD","AIFD","GAMR","LU2413666699.HKD","LU1720050803.USD","LU1815333072.USD","LU1720051017.SGD","LU1808992512.USD","LU0708995153.HKD","LU0868494708.USD","LU0762541174.USD","LU2272731782.SGD","LU2237443549.SGD","LU0689472784.USD","SGXZ51526630.SGD","LU0577902298.EUR","LU0359201885.HKD","LU0630378692.HKD","LU1868836757.USD","LU0469268626.HKD","LU0106261372.USD","LU1770036033.HKD","LU0124676726.USD","SG9999001051.SGD","LU2322448957.HKD","LU0289961442.SGD","LU0965509010.AUD","LU1153585028.USD","LU2462591350.SGD","BK4141","LU1251922891.USD","LU0079474960.USD","LU0787776722.HKD","LU1868838027.USD","LU2125910849.SGD","IE0004086264.USD","LU2357125470.USD","IE000YTNTUN2.SGD","LU2148611432.USD","FDNI","BK4148","LU0540923850.HKD","LU2403377893.USD","LU0234572021.USD","LU0390134368.USD","LU0077335932.USD","LU0823434740.USD","MCHmain","NVDG","SG9999015341.SGD","LU0314109678.HKD","LU0214875030.USD","LU1923622291.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662276478","title":"Hong Kong's SSY Group H1 Profit Rises on Infusion Solutions Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662276478","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662276478?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:16","pubTimestamp":1787717785,"startTime":"0","endTime":"0","summary":"Hong Kong's SSY Group H1 profit rises on infusion solutions growthOverviewHong Kong pharmaceutical maker's H1 revenue rose 9.9% yr/yr to HK$2,361 mlnNet profit attributable to shareholders rose 13% to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N037:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","KURE","LU2460026573.USD","HK0000165453.HKD","LU2097828557.USD","LU0244354667.USD","01801","BK1589","LU0326950275.SGD","LU2097828474.EUR","LU0463099449.HKD","BK1583","LU0455707207.USD","BK1191","LU1969619763.USD","LU2097828714.EUR","02005","LU2097828631.EUR","LU0502904849.HKD","LU2488822045.USD","LU1188198961.HKD","LU2097828805.USD","BK1161","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662176420","title":"Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2662176420","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662176420?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:15","pubTimestamp":1787717732,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical H1 profit jumps on medical aesthetics unit strengthOverviewChina pharmaceutical group's interim revenue rose 1.3% yr/yr, led by medical aesthetics growthNet income attributable t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N039:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","LU0072913022.USD","IE00B031HY20.USD","LU0244354667.USD","LU1328277881.USD","LU1008478684.HKD","LU1807302812.USD","LU1226288170.HKD","LU0501845795.SGD","IE0008369823.USD","LU2488822045.USD","LU1960683339.HKD","LU1969619763.USD","LU2097828631.EUR","LU1226287529.USD","01801","LU1813983027.USD","LU2097828474.EUR","LU0140636845.USD","IE00BZ08YS42.EUR","BK1593","LU1188198961.HKD","HK0000165453.HKD","LU2039709279.SGD","LU1226288253.USD","LU0463099449.HKD","BK0239","01093","LU0455707207.USD","688428","KURE","LU0067412154.USD","LU2097828805.USD","LU0314109678.HKD","SG9999004220.SGD","BK1161","BK1515","LU1152091754.HKD","LU2328871848.SGD","IE00B543WZ88.USD","LU2242644610.SGD","BK1191","IE00B5MMRT66.SGD","LU2097828714.EUR","BK1583","LU1152091168.USD","LU0880133367.SGD","BK1589","BK1600","LU0502904849.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154655464","title":"Morning Market Wrap: Hong Kong Shares Rise 0.68% as Copper Stocks Take the Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=1154655464","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154655464?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:07","pubTimestamp":1787717221,"startTime":"0","endTime":"0","summary":"Hong Kong's benchmark index kicked off the morning session with a 0.68% gain, advancing 174 points to reach 25,685 points, while the tech-heavy Hang Seng Tech Index climbed a more robust 1.58%....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0561508036.HKD","IE00BZ08YT58.USD","LU1813983027.USD","BK1191","03032","BK1184","BK1568","BK1597","LU0244354667.USD","IE00BVYPNQ40.USD","LU1048596156.SGD","LU0594300179.USD","09088","LU0348783233.USD","IE00B5MMRT66.SGD","07552","09067","SG9999002828.SGD","06099","LU2476274308.USD","BK1521","HTImain","LU0650527681.SGD","LU2476274720.SGD","03037","600362","BK1190","IE0031814852.USD","SG9999002950.SGD","LU0594300419.USD","IE0008369823.USD","BK1564","BK1574","03993","HK0000286598.CNH","BK1149","LU0828237940.HKD","LU1961090484.USD","09926","LU0348827113.USD","LU0607220059.USD","BK1501","LU1880383440.USD","LU1023057109.AUD","BK1580","LU1188198961.HKD","LU0181495838.USD","IE00B29SXG58.USD","LU1720050803.USD","LU1794554557.SGD","LU1328277881.USD","03417","IE00BZ08YR35.GBP","LU0348767384.USD","LU0890818403.SGD","LU0708995583.HKD","HSImain","83115","82800","LU2187417386.USD","BK1227","LU2045819591.USD","SG9999004311.SGD","BK1147","LU0405327148.USD","HSTECH","BK1589","IE00BGHQDM52.EUR","BK1242","LU0359201885.HKD","03908","LU0326950275.SGD","LU0463099449.HKD","09115","LU0862451837.USD","06166","LU1481107354.HKD","BK1233","LU0348766576.USD","03088","MCHmain","HSI","BK1206","IE00B031HY20.USD","LU0140636845.USD","LU0417516738.SGD","LU2125910500.SGD","LU2039709279.SGD","02800","LU1102505929.USD","LU0359202008.SGD","LU1880383366.USD","600999","01112","IE00B543WZ88.USD","LU0359201612.USD","BK1516","02837","IE00B031J352.USD","HHImain","03067","688185","SG9999014674.SGD","02575","LU0405327494.USD","LU1831875114.USD","LU2351347302.SGD","LU0417516571.SGD","07500","603083","LU0164880469.USD","LU0348825331.USD","LU0862451753.SGD","LU2213484517.USD","IE0008368742.USD","LU0348784397.USD","LU0314109678.HKD","LU0540923850.HKD","IE00BYV24P56.USD","BK1513","603993","IE00BMCWC346.EUR","BK1592","LU0149534421.HKD","BK1515","LU0052750758.USD","LU0149721374.USD","LU2488822045.USD","BK1240","BK1553","KURE","02833","LU0417516902.SGD","BK1594","BK1161","LU2778985437.USD","03115","07200","LU0348735423.USD","LU2929501877.USD","LU0320764599.SGD","LU1102505762.USD","513600","BK1237","03419","06185","00358","LU2399975544.HKD","02313","06831","07226","07300","601995","IE00BVYPNP33.GBP","LU0634319403.HKD","06969","LU0821914370.USD","01258","IE00BZ08YS42.EUR","SG9999004220.SGD","03423","LU0605514214.HKD","03033","01828","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128522297","title":"Mainland Benchmarks Edge Higher in Morning Trade; Nonferrous Metals and Brokerages Lead While Optical Modules Retreat; Hang Seng and Tech Index Climb Over 1% on Biotech Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1128522297","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128522297?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:38","pubTimestamp":1787711889,"startTime":"0","endTime":"0","summary":"Mainland Chinese equities extended gains on August 26, with all three major indices moving higher in early trading. Precious and base metals sustained their upward momentum, while brokerages and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HHImain","03417","LU1969619763.USD","000001","LU0880133367.SGD","02833","LU0244354667.USD","LU1781817850.SGD","BK0028","LU2097828631.EUR","LU1807302812.USD","LU0455707207.USD","LU2488822045.USD","07200","BK0278","03423","LU1188198961.HKD","BK0183","07300","03088","LU0067412154.USD","03037","07552","02837","03115","IE00B0JY6N72.USD","09067","LU1580142542.USD","03033","07226","03419","LU2097828557.USD","LU1226287529.USD","LU2097828805.USD","01801","BK0187","03032","LU2328871848.SGD","LU1993786604.SGD","HSI","BK0188","513600","LU2097828714.EUR","HK0000165453.HKD","82800","LU0501845795.SGD","161726","BK1589","LU2097828474.EUR","HTImain","LU2242644610.SGD","HSTECH","HSImain","LU0463099449.HKD","LU0326950275.SGD","09088","BK1161","83115","BK0201","LU1655091616.SGD","07500","KURE","BK0012","02800","09115","03067","MCHmain","LU0502904849.HKD","BK1583","LU0072913022.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662769060","title":"China's Akeso Jumps on Progress of Immunotherapy Drug for Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662769060","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662769060?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:33","pubTimestamp":1787711596,"startTime":"0","endTime":"0","summary":"BUZZ-China's Akeso jumps on progress of immunotherapy drug for cancer treatment** Shares of China-based drug developer Akeso Inc9926.HKjump 9% to HK$96.9, on track for the biggest one-day pct gain since June 29** Stock hits the highest level since August 20 in the second gaining session** Akeso saysivonescimab plus chemomeets primary endpoint with significant overall survival benefit versus durvalumab plus chemo in phase III clinical study for the first-line treatment of advanced biliary tract cancer** The study met all key secondary endpoints of progression-free survival and objective response rate - Co** YTD, stock down 14.8%, while Hang Seng Biotech Index.HSBIOup 15.7%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N025:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2476274720.SGD","BK1161","LU1961090484.USD","09926","KURE","LU0540923850.HKD","LU0634319403.HKD","LU0561508036.HKD","IE00B5MMRT66.SGD","LU2476274308.USD","IE00BPRC5H50.USD","LU1794554557.SGD","LU2778985437.USD","LU0348784397.USD","LU2488822045.USD","LU0348783233.USD","LU0348827113.USD","BK1574","LU0348766576.USD","LU0348735423.USD","LU0348825331.USD","IE00B543WZ88.USD","LU0348767384.USD","LU0417516738.SGD","LU1720050803.USD","LU0417516571.SGD","LU0417516902.SGD","LU2399975544.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147226125","title":"AKESO Surges Over 9% in Session as Evonex Achieves Positive Phase III Results in Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1147226125","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147226125?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:31","pubTimestamp":1787711462,"startTime":"0","endTime":"0","summary":"Shares of AKESO (09926) surged more than 9% during intraday trading before paring gains to trade 6.81% higher at HK$94.85, with turnover reaching HK$814 million. The sharp move followed the company's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0561508036.HKD","LU0417516902.SGD","LU2476274308.USD","LU2488822045.USD","LU0348735423.USD","LU2778985437.USD","LU0348784397.USD","LU1961090484.USD","BK1574","LU0417516738.SGD","BK4134","IE00B5MMRT66.SGD","LU0348783233.USD","LU1794554557.SGD","LU0540923850.HKD","LU0348766576.USD","LU0348827113.USD","09926","LU2399975544.HKD","LU2476274720.SGD","LU0417516571.SGD","III","LU0348825331.USD","BK1161","LU1720050803.USD","KURE","LU0634319403.HKD","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662766269","title":"Akeso's Ivonescimab Meets Primary Endpoint in Phase 3 Biliary Tract Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662766269","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662766269?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:41","pubTimestamp":1787708502,"startTime":"0","endTime":"0","summary":"Akeso  said its PD-1/VEGF bispecific antibody ivonescimab plus chemotherapy met the primary endpoint in a Phase 3 trial for first-line treatment of advanced biliary tract cancer.The trial met its primary endpoint of overall survival, with key secondary endpoints of progression-free survival and objective response rate also met, according to a Wednesday filing with the Hong Kong bourse.The HARMONi-GI1 study enrolled 682 patients, marking ivonescimab's first positive Phase 3 result in gastrointestinal tumors, Akeso said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0561508036.HKD","LU2488822045.USD","LU1720050803.USD","KURE","LU1794554557.SGD","LU0417516902.SGD","IE00B543WZ88.USD","BK1161","LU0348767384.USD","LU2778985437.USD","LU0348735423.USD","LU0348783233.USD","IE00B5MMRT66.SGD","LU2476274308.USD","LU0417516571.SGD","LU2476274720.SGD","LU0348825331.USD","LU2399975544.HKD","LU0348784397.USD","LU0634319403.HKD","LU0540923850.HKD","BK1574","LU1961090484.USD","09926","LU0348827113.USD","LU0348766576.USD","LU0417516738.SGD","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662766696","title":"Akeso Says Ivonescimab Plus Chemo Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2662766696","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662766696?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:29","pubTimestamp":1787707747,"startTime":"0","endTime":"0","summary":"BRIEF-Akeso Says Ivonescimab Plus Chemo Meets Primary EndpointAug 26 (Reuters)-Akeso Inc9926.HK:IVONESCIMAB PLUS CHEMO MEETS PRIMARY ENDPOINT WITH SIGNIFICANT OS BENEFIT IN 1L BTCFurther company coverage:9926.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44M0TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1794554557.SGD","KURE","LU0417516571.SGD","09926","LU0540923850.HKD","LU0348766576.USD","LU1720050803.USD","LU2476274720.SGD","LU2476274308.USD","BK1161","LU2488822045.USD","LU0348735423.USD","LU2778985437.USD","IE00BPRC5H50.USD","LU0561508036.HKD","IE00B543WZ88.USD","LU0348825331.USD","LU0417516902.SGD","LU1961090484.USD","LU0348827113.USD","LU0634319403.HKD","LU2399975544.HKD","LU0348783233.USD","BK1574","IE00B5MMRT66.SGD","LU0348784397.USD","LU0417516738.SGD","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114601608","title":"INNOVENT BIO Surges 6% on Robust H1 Earnings, Sets Ambitious 2030 Revenue Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1114601608","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114601608?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:28","pubTimestamp":1787707707,"startTime":"0","endTime":"0","summary":"Shares of INNOVENT BIO (01801) opened more than 6% higher on Thursday, extending gains to 6.49% at HK$106.60 with turnover reaching HK$28.73 million in early trading.The rally follows the company's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828714.EUR","LU0455707207.USD","KURE","BK1589","LU2097828805.USD","LU1188198961.HKD","LU2097828631.EUR","BK4588","LU2097828557.USD","LU0502904849.HKD","LU1969619763.USD","BK1161","LU0244354667.USD","LU2242644610.SGD","KCAI","LU2328871848.SGD","LU0326950275.SGD","HK0000165453.HKD","LU0463099449.HKD","LU2097828474.EUR","VXUS","BK1583","BK4585","LU2488822045.USD","01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115078027","title":"HK Stock Market Highlights: Haizhi Tech's H1 FY2026 Revenue Jumps 70.4% as Agent Business Takes Off","url":"https://stock-news.laohu8.com/highlight/detail?id=1115078027","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115078027?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:17","pubTimestamp":1787707028,"startTime":"0","endTime":"0","summary":"Key corporate developments this week: GenFleet Therapeutics-B (02595) has initiated a Phase II study evaluating GFH375, an oral KRAS G12D inhibitor, as a first-line treatment for non-small cell lung...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0634319403.HKD","LU0348783233.USD","LU0417516902.SGD","LU2476274720.SGD","BK4585","BK1589","BK4588","BK1586","LU0540923850.HKD","VXUS","LU1794554557.SGD","LU0348827113.USD","IE00B543WZ88.USD","LU0417516738.SGD","02595","BK1526","LU0417516571.SGD","BK1518","BK1161","LU0348825331.USD","LU0561508036.HKD","LU2778985437.USD","KCAI","LU2476274308.USD","LU0348784397.USD","BK1237","IE00BPRC5H50.USD","KURE","LU0348735423.USD","BK1574","LU0348767384.USD","00354","LU1961090484.USD","BK1155","LU1720050803.USD","LU2488822045.USD","09926","IE00B5MMRT66.SGD","LU0348766576.USD","LU2399975544.HKD","00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169767752","title":"JPMorgan Raises Stake in Innovent Bio With HK$241M Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1169767752","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169767752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 08:10","pubTimestamp":1787703042,"startTime":"0","endTime":"0","summary":"Hong Kong stock exchange filings reveal that on August 20, JPMorgan increased its holding in INNOVENT BIO (01801) by 2.355 million shares.The purchase was executed at an average price of HK$102.2359...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","LU2106854487.HKD","LU0211327993.USD","LU0323591593.USD","JPM","IE00BKDWB100.SGD","LU0208291251.USD","BK4534","LU2237443382.USD","LU0070302665.USD","IE00BHPRN162.USD","IE00BDRTCR15.USD","LU2242649171.HKD","LU0244354667.USD","LU1668664300.SGD","LU1894683264.USD","LU1917777945.USD","BK4550","LU0187121727.USD","LU0345770308.USD","BK1589","SG9999002224.SGD","LU2456880835.USD","LU0820562030.AUD","LU1261432733.SGD","TFNS","LU0463099449.HKD","LU2746668974.SGD","LU2462157665.USD","LU2756315664.SGD","LU2054465674.USD","BK4504","IE0034235303.USD","LU0256863811.USD","LU2505996509.AUD","LU0320765489.SGD","LU2357305700.SGD","JPMO","LU0820561909.HKD","LU0868494708.USD","LU0006306889.USD","LU0502904849.HKD","LU2023250504.SGD","LU1551013425.SGD","IXG","LU2430703095.HKD","LU0320765646.SGD","FNCL","IE0034235188.USD","LU1366192091.USD","LU2357627491.SGD","LU0942090050.USD","LU1116320737.USD","IE00BLSP4452.SGD","LU0215105999.USD","LU0234570918.USD","LU2328871848.SGD","LU2430703251.USD","IE00B3S45H60.SGD","LU1084165304.USD","LU1032466523.USD","LU2097828557.USD","LU0048584097.USD","IE00BJTD4V19.USD","01801","LU1280957306.USD","LU1914381329.SGD","LU1894683348.USD","LU0256863902.USD","LU2211815571.USD","LU2236285917.USD","LU0106261372.USD","LU0683600562.USD","LU1145028129.USD","IE00BZ1G4Q59.USD","LU1244550577.SGD","LU1363072403.SGD","LU0964807845.USD","KBWB","BK4516","LU0310799852.SGD","LU0455707207.USD","LU0417517546.SGD","LU1670627923.USD","LU1969619763.USD","LU1551013342.USD","IE00B775SV38.USD","LU2097828714.EUR","LU0267386448.USD","LU2244417387.USD","LU2237443895.HKD","LU0203345920.USD","LU2381873111.SGD","LU1720051108.HKD","JPO","LU1064131342.USD","LU2756315318.SGD","LU2746668461.USD","BK1161","LU1116320901.HKD","IE00BWXC8680.SGD","LU0265550946.USD","LU2417539215.USD","LU0787776722.HKD","LU1162221912.USD","LU2552382058.USD","LU2237443549.SGD","HK0000165453.HKD","LU1988902786.USD","BK4207","LU0345769631.USD","IE00BJLML261.HKD","LU2592432038.USD","LU0265550359.USD","UYG","BK4533","LU2237443978.SGD","LU0326950275.SGD","LU1974910355.USD","LU0859254822.USD","LU1720051017.SGD","LU0211331839.USD","LU0106831901.USD","LU0976567544.SGD","FTXO","LU2023250330.USD","XLF","LU2552382215.SGD","LU2237443622.USD","LU2264538146.SGD","LU2552382132.HKD","LU0203347892.USD","LU0170899867.USD","IE00BK4W5L77.USD","LU1244550221.USD","LU1629891620.HKD","LU2213496289.HKD","LU0943347566.SGD","LU2488822045.USD","EWH","LU1188198961.HKD","LU1496350171.SGD","LU0689472784.USD","LU0345770993.USD","IE0034235295.USD","LU0882574139.USD","LU0868494617.USD","LU0251132253.USD","IYF","KURE","LU1670628061.USD","LU0640476718.USD","LU0234572021.USD","IE00BDCRKT87.USD","IE00BN8TJ469.HKD","LU0211326839.USD","BK4588","IE00BBT3K403.USD","IE00BK4W5M84.HKD","LU0211328371.USD","IE00BFXG1179.USD","LU0345769128.USD","LU0496365809.HKD","LU1244550494.USD","LU1548497426.USD","LU2505996681.GBP","LU0971096721.USD","LU1267930490.SGD","LU1496350502.SGD","IE000M9KFDE8.USD","IE00BLSP4239.USD","LU2097828474.EUR","LU0149725797.USD","LU1119994496.HKD","VFH","LU2023250843.SGD","BK1583","IE00BKVL7J92.USD","IE00B1BXHZ80.USD","IE00B1XK9C88.USD","TRUF","LU0238689110.USD","IE00BYXW3230.USD","LU2097828631.EUR","BK4585","BK4566","LU0211326755.USD","LU2430703178.SGD","LU0820561818.USD","IE00BJTD4N35.SGD","IYG","LU2097828805.USD","SG9999002232.USD","BK4581","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197055899","title":"AKESO's Novel Dual Antibody Achieves Positive Phase III Results in Biliary Tract Cancer, Marking First Solid Tumor Expansion Beyond Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1197055899","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197055899?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:42","pubTimestamp":1787701336,"startTime":"0","endTime":"0","summary":"AKESO (09926) has announced that its independently developed, first-in-class bispecific antibody, 依达方® (ivonescimab, PD-1/VEGF), combined with chemotherapy, demonstrated a statistically significant...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348766576.USD","LU0634319403.HKD","BK1574","LU2488822045.USD","LU0348735423.USD","LU0348783233.USD","LU1961090484.USD","IE00BPRC5H50.USD","LU0540923850.HKD","LU1720050803.USD","LU2778985437.USD","BK4134","LU2476274308.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0348784397.USD","LU0417516571.SGD","LU2476274720.SGD","LU1794554557.SGD","KURE","LU0417516738.SGD","III","LU0348825331.USD","LU0348767384.USD","BK1161","LU0561508036.HKD","09926","LU0417516902.SGD","LU0348827113.USD","LU2399975544.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662685897","title":"Akeso - Ivonescimab Plus Chemo Meets Primary Endpoint with Significant Os Benefit in 1L BTC","url":"https://stock-news.laohu8.com/highlight/detail?id=2662685897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662685897?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:01","pubTimestamp":1787698884,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2476274720.SGD","BK1161","LU1961090484.USD","09926","KURE","LU0540923850.HKD","LU0634319403.HKD","LU0561508036.HKD","IE00B5MMRT66.SGD","LU2476274308.USD","IE00BPRC5H50.USD","LU1794554557.SGD","LU2778985437.USD","LU0348784397.USD","LU2488822045.USD","LU0348783233.USD","LU0348827113.USD","BK1574","LU0348766576.USD","LU0348735423.USD","LU0348825331.USD","IE00B543WZ88.USD","LU0348767384.USD","LU0417516738.SGD","LU1720050803.USD","LU0417516571.SGD","LU0417516902.SGD","LU2399975544.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}